Agency Information Collection Activities: Proposed Collection: Public Comment Request Information Collection Request Title: Health Center Program: COVID-19 Data Collection Tools, OMB No. 0906-0062-Revision, 41974-41976 [2021-16591]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
41974
Federal Register / Vol. 86, No. 147 / Wednesday, August 4, 2021 / Notices
The burden estimates are based on
FDA’s experience with voluntary recalls
under 21 CFR part 7. FDA expects no
more than two mandatory recalls per
year, as most recalls are done
voluntarily.
Section 810.10(d)—Collections
Specified in the Order—(Reporting)—
FDA may require the person named in
the cease distribution and notification
order to submit certain information to
the Agency, e.g., distribution
information, progress reports.
Section 810.11(a)—Request for
Regulatory Hearing—(Reporting)—A
request for regulatory hearing regarding
the cease distribution and notification
order must be submitted in writing to
FDA.
Section 810.12(a) and (b)—Written
Request for Review—(Reporting)—In
lieu of requesting a regulatory hearing
under § 810.11, the person named in the
cease distribution and notification order
may submit a written request to FDA
asking that the order be modified or
vacated. A written request for review of
a cease distribution and notification
order shall identify each ground upon
which the requestor relies in asking that
the order be modified or vacated,
address an appropriate cease
distribution and notification strategy,
and address whether the order should
be amended to require a recall of the
device that was the subject of the order
and the actions required by such a recall
order.
Section 810.14—Mandatory Recall
Strategy—(Reporting)—The person
named in the cease distribution and
notification order or a mandatory recall
order must develop and submit a
strategy to FDA for complying with the
order that is appropriate for the
individual circumstances.
Section 810.15(a) through (c)—
Notifications to Recipients—(ThirdParty Disclosure)—The person named in
a cease distribution and notification
order or a mandatory recall order must
promptly notify each health
professional, user facility, consignee, or
individual of the order.
Section 810.15(b)—Documentation of
Notifications to Recipients—
(Recordkeeping)—Telephone calls or
other personal contacts may be made in
addition to, but not as a substitute for,
the verified written communication, and
shall be documented in an appropriate
manner.
Section 810.15(d)—Notification to
Recipients; Followup—(Third-Party
Disclosure)—The person named in the
cease distribution and notification order
or mandatory recall order shall ensure
that followup communications are sent
VerDate Sep<11>2014
16:45 Aug 03, 2021
Jkt 253001
to all who fail to respond to the initial
communication.
Section 810.15(e)—Notification of
Consignees by Recipients—(Third-Party
Disclosure)—Health professionals,
device user facilities, and consignees
should immediately notify their
consignees of the order.
Section 810.16(a) and (b)—Periodic
Status Reports—(Reporting)—The
person named in a cease distribution
and notification order or a mandatory
recall order must submit periodic status
reports to FDA to enable the Agency to
assess the person’s progress in
complying with the order. The
frequency of such reports and the
Agency official to whom such reports
must be submitted will be specified in
the order.
Section 810.17(a)—Termination
Request—(Reporting)—The person
named in a cease distribution and
notification order or a mandatory recall
order may request termination of the
order by submitting a written request to
FDA. The person submitting a request
must certify that he or she has complied
in full with all the requirements of the
order and shall include a copy of the
most current status report submitted to
the Agency.
Based on a review of the information
collection since our last request for
OMB approval, we have made no
changes to the burden estimate.
Dated: July 26, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
[FR Doc. 2021–16635 Filed 8–3–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request Information
Collection Request Title: Health Center
Program: COVID–19 Data Collection
Tools, OMB No. 0906–0062—Revision
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
SUMMARY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than September 3,
2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under Review—Open for
Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Lisa Wright-Solomon, the HRSA
Information Collection Clearance Officer
at (301) 443–1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Health Center Program: COVID–19 Data
Collection Tools, OMB No. 0906–0062—
Revision.
Abstract: This information collection
request was previously approved by
OMB on June 11, 2020, as an emergency
clearance (OMB No.: 0906–0062). HRSA
is currently undertaking the standard
Paperwork Reduction Act process for
normal OMB approval.
During the COVID–19 public health
emergency, HRSA-supported health
centers and Federally Qualified Health
Center Look-Alikes (look-alikes) have
played a key role in providing testing
and care for those affected by the virus.
HRSA has awarded billions of dollars in
new funding to support health center
awardees and look-alikes in the
detection, prevention, diagnosis, and
treatment of COVID–19. This funding
has enabled health centers to maintain
or increase their staffing levels, conduct
training, provide COVID–19 treatment,
and administer millions of tests for both
existing and new patients. In addition,
HRSA, in collaboration with the Centers
for Disease Control and Prevention,
launched the Health Center COVID–19
Vaccine program as part of an
Administration initiative focused on
health equity. This occurred in February
2021 to directly allocate COVID–19
vaccines to HRSA-supported health
centers.
This ICR to support the
implementation of COVID–19 relief
funding and response activities includes
forms previously submitted in the
emergency information collection
E:\FR\FM\04AUN1.SGM
04AUN1
41975
Federal Register / Vol. 86, No. 147 / Wednesday, August 4, 2021 / Notices
request clearance: (1) Health Center
COVID–19 Data Collection Survey Tool,
(2) Addendum to COVID–19 Data
Collection Survey Tool, and (3) the
Health Center COVID–19 Vaccine
Program Readiness Assessment Tool.
This revised information collection
request also includes two newly added
forms: (1) Primary Care Association
(PCA) COVID–19 Data Collection
Survey Tool 1 and (2) the Health Center
COVID–19 Vaccine Program Conditions
of Participation Agreement.
A 60-day notice published in the
Federal Register on April 23, 2021, vol.
86, No. 77; pp. 21756–57. There were no
public comments.
Need and Proposed Use of the
Information: HRSA uses the data
collected to optimize COVID–19 testing
and vaccination; track health center
capacity and the impact of COVID–19
on operations, patients, and staff; and
better understand training and technical
assistance, funding, and other health
center resource needs. The data allow
HRSA to assess health center capacity
prior to program enrollment, supporting
successful vaccine allocation strategies,
while providing HRSA with information
on the effectiveness of vaccine
distribution through this program. In
addition, the data inform HRSA in
resource allocation and technical
assistance to health centers.
The readiness assessment supports
HRSA’s analysis of health center ability
to successfully participate in the Health
Center COVID–19 Vaccine Program.
These data are critical to determine
health center capacity to implement the
vaccination program as well as comply
with program requirements. These data
are used to assess program readiness
including:
• Ability to safely store the vaccine
• Availability of trained and
credentialed staff and other staff
capacity
• Reporting capacity
• Sufficient PPE
• Plan for vaccine transport
The health center weekly survey and
addendum support HRSA’s ability to
monitor progress towards the
development and delivery of COVID–19
prevention, preparedness, and/or
response activities; and ensure
appropriate vaccine administration as
well as better understand training and
technical assistance, funding, and other
health center resource needs.
The Conditions of Participation
Agreement governs all COVID–19
vaccination activities at all health center
sites that receive COVID–19 vaccine
through the HRSA Health Center
COVID–19 Vaccine Program. Health
Centers that sign the agreement agree to
adhere to each of the stated
requirements.
The PCA weekly survey increases
information sharing between health
centers, PCAs, and HRSA in order to
better support COVID–19 emergency
response efforts inclusive of testing and
vaccination activities. Data collected
from the survey tool is used to track and
monitor issues/challenges to program
implementation and assess the need for
the delivery/dissemination of targeted
training and technical assistance.
Likely Respondents: HRSA-supported
health centers, look-alikes, and PCAs.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
lotter on DSK11XQN23PROD with NOTICES1
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses to
form per
respondent
Total
responses
Average
burden
per response
(in hours)
Total
burden
hours
Form name
Number of respondents
Condition of Participation Agreement
(one-time completion for vaccine
program participants only).
Readiness Assessment Tool (onetime completion for vaccine program participants only).
Health Center COVID–19 Data Collection Survey Tool (weekly completion of existing 20 questions).
Addendum to COVID–19 Data Collection Survey Tool (weekly completion for vaccine program participants only).
PCA COVID–19 Data Collection Survey Tool (bi-weekly completion of
existing six questions).
1,467 (Total health centers, including look-alikes, in 2019).
1
1,467
.25
366.75
1,467 (Total health centers, including look-alikes, in 2019).
1
1,467
.50
733.50
1,389 (Total health centers in 2019)
48
66,672
1.00
66,672.00
1,389 (Total health centers in 2019)
48
66,672
.50
33,336.00
52 .....................................................
6
312
.75
234.00
Total ...........................................
5,764 ................................................
........................
136,590
........................
101,342.25
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
1 The bi-weekly COVID–19 PCA Survey Tool
(comprised of six questions) is currently approved
under the HHS Secretary’s Public Health
Emergency Authority to waive the requirements of
the Paperwork Reduction Act during the Public
Health Emergency for reporting on a voluntary
basis.
VerDate Sep<11>2014
16:45 Aug 03, 2021
Jkt 253001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
E:\FR\FM\04AUN1.SGM
04AUN1
41976
Federal Register / Vol. 86, No. 147 / Wednesday, August 4, 2021 / Notices
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021–16591 Filed 8–3–21; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Charter Amendment for the Advisory
Committee on Heritable Disorders in
Newborns and Children
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act
(FACA) and section 1111 of the Public
Health Service (PHS) Act, HHS is
hereby giving notice that the charter for
the Advisory Committee on Heritable
Disorders in Newborns and Children
(ACHDNC) has been amended to set the
time period for appointment of members
to a term of up to 4 years. The effective
date of the amendment is July 30, 2021.
FOR FURTHER INFORMATION CONTACT: Mia
Morrison (DFO), Maternal and Child
Health Bureau, HRSA, 5600 Fishers
Lane, Rockville, Maryland 20857; 301–
443–2521; or mmorrison@hrsa.gov.
SUPPLEMENTARY INFORMATON: The
ACHDNC provides advice and
recommendations to the Secretary of
HHS on policy, program development,
and other matters of significance
concerning certain activities described
in section 1111 of the PHS Act (42
U.S.C. 300b–10), as further described
below. The ACHDNC is also governed
by the provisions of the FACA, as
amended (5 U.S.C. App.), which sets
forth standards for the formation and
use of advisory committees. The
ACHDNC advises the Secretary of HHS
about aspects of newborn and childhood
screening and technical information for
the development of policies and
priorities that will enhance the ability of
the state and local health agencies to
provide for newborn and child
screening, counseling and health care
services for newborns and children
having, or at risk for, heritable
disorders. The ACHDNC will review
and report regularly on newborn and
childhood screening practices,
recommend improvements in the
national newborn and childhood
screening programs, and fulfill
responsibilities described in section
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:45 Aug 03, 2021
Jkt 253001
1111 of the PHS Act. In addition, the
ACHDNC’s recommendations regarding
inclusion of additional conditions for
screening, following adoption by the
Secretary, are considered evidenceinformed preventive health services
provided for in the comprehensive
guidelines supported by HRSA through
the Recommended Uniform Screening
Panel (RUSP) pursuant to section 2713
of the PHS Act (42 U.S.C. 300gg–13).
Under this provision, non-grandfathered
group health plans and health insurance
issuers offering group or individual
health insurance are required to provide
insurance coverage without cost-sharing
(a co-payment, co-insurance, or
deductible) for preventive services for
plan years (i.e., policy years) beginning
on or after the date that is one year from
the Secretary’s adoption of the
condition for screening.
The filing date of the ACHDNC
charter remains November 10, 2020. A
copy of the ACHDNC charter is
available on the ACHDNC website at
https://www.hrsa.gov/advisorycommittees/heritable-disorders/
index.html. A copy of the charter also
can be obtained by accessing the FACA
database that is maintained by the
Committee Management Secretariat
under the General Services
Administration. The website address for
the FACA database is https://
www.facadatabase.gov/.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021–16618 Filed 8–3–21; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request Information
Collection Request Title: National
Health Service Corps Scholar/Students
To Service Travel Worksheet, OMB No.
0915–0278—Extension
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than October 4, 2021.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 14N136B, 5600 Fishers
Lane, Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Lisa Wright-Solomon, the HRSA
Information Collection Clearance Officer
at (301) 443–1984.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference.
Information Collection Request Title:
National Health Service Corps Scholar/
Students to Service Travel Worksheet,
OMB No. 0915–0278—Extension.
Abstract: Clinicians participating in
the HRSA National Health Service
Corps (NHSC) Scholarship Program (SP)
and the Students to Service (S2S) Loan
Repayment Program (LRP) use the
online Travel Request Worksheet to
request and receive travel funds from
the federal government to visit eligible
NHSC sites to which they may be
assigned in accordance with the Public
Health Service Act, section 331(c)(1).
The travel approval process is
initiated when an NHSC scholar or S2S
participant notifies the NHSC of an
impending interview at one or more
NHSC-approved practice sites. The
Travel Request Worksheet is also used
to initiate the relocation process after a
NHSC scholar or S2S participant has
successfully been matched to an
approved practice site in accordance
with the Public Health Service Act,
section 331(c)(3). Upon receipt of a
completed Travel Request Worksheet,
the NHSC will review and approve or
disapprove the request and promptly
notify the scholar or S2S participant and
the NHSC logistics contractor regarding
travel arrangements and authorization of
the funding for the site visit or
relocation.
Need and Proposed Use of the
Information: This information will
facilitate NHSC scholar and S2S
participants’ receipt of federal travel
funds that are used to visit high-need
NHSC-approved practice sites. The
Travel Request Worksheet is also used
to initiate the relocation process after a
NHSC scholar or S2S participant has
E:\FR\FM\04AUN1.SGM
04AUN1
]]>Agencies
[Federal Register Volume 86, Number 147 (Wednesday, August 4, 2021)]
[Notices]
[Pages 41974-41976]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16591]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection:
Public Comment Request Information Collection Request Title: Health
Center Program: COVID-19 Data Collection Tools, OMB No. 0906-0062--
Revision
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement for opportunity for public
comment on proposed data collection projects of the Paperwork Reduction
Act of 1995, HRSA announces plans to submit an Information Collection
Request (ICR), described below, to the Office of Management and Budget
(OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the
public regarding the burden estimate, below, or any other aspect of the
ICR.
DATES: Comments on this ICR should be received no later than September
3, 2021.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under Review--Open for
Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
draft instruments, email [email protected] or call Lisa Wright-
Solomon, the HRSA Information Collection Clearance Officer at (301)
443-1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: Health Center Program: COVID-
19 Data Collection Tools, OMB No. 0906-0062--Revision.
Abstract: This information collection request was previously
approved by OMB on June 11, 2020, as an emergency clearance (OMB No.:
0906-0062). HRSA is currently undertaking the standard Paperwork
Reduction Act process for normal OMB approval.
During the COVID-19 public health emergency, HRSA-supported health
centers and Federally Qualified Health Center Look-Alikes (look-alikes)
have played a key role in providing testing and care for those affected
by the virus. HRSA has awarded billions of dollars in new funding to
support health center awardees and look-alikes in the detection,
prevention, diagnosis, and treatment of COVID-19. This funding has
enabled health centers to maintain or increase their staffing levels,
conduct training, provide COVID-19 treatment, and administer millions
of tests for both existing and new patients. In addition, HRSA, in
collaboration with the Centers for Disease Control and Prevention,
launched the Health Center COVID-19 Vaccine program as part of an
Administration initiative focused on health equity. This occurred in
February 2021 to directly allocate COVID-19 vaccines to HRSA-supported
health centers.
This ICR to support the implementation of COVID-19 relief funding
and response activities includes forms previously submitted in the
emergency information collection
[[Page 41975]]
request clearance: (1) Health Center COVID-19 Data Collection Survey
Tool, (2) Addendum to COVID-19 Data Collection Survey Tool, and (3) the
Health Center COVID-19 Vaccine Program Readiness Assessment Tool. This
revised information collection request also includes two newly added
forms: (1) Primary Care Association (PCA) COVID-19 Data Collection
Survey Tool \1\ and (2) the Health Center COVID-19 Vaccine Program
Conditions of Participation Agreement.
---------------------------------------------------------------------------
\1\ The bi-weekly COVID-19 PCA Survey Tool (comprised of six
questions) is currently approved under the HHS Secretary's Public
Health Emergency Authority to waive the requirements of the
Paperwork Reduction Act during the Public Health Emergency for
reporting on a voluntary basis.
---------------------------------------------------------------------------
A 60-day notice published in the Federal Register on April 23,
2021, vol. 86, No. 77; pp. 21756-57. There were no public comments.
Need and Proposed Use of the Information: HRSA uses the data
collected to optimize COVID-19 testing and vaccination; track health
center capacity and the impact of COVID-19 on operations, patients, and
staff; and better understand training and technical assistance,
funding, and other health center resource needs. The data allow HRSA to
assess health center capacity prior to program enrollment, supporting
successful vaccine allocation strategies, while providing HRSA with
information on the effectiveness of vaccine distribution through this
program. In addition, the data inform HRSA in resource allocation and
technical assistance to health centers.
The readiness assessment supports HRSA's analysis of health center
ability to successfully participate in the Health Center COVID-19
Vaccine Program. These data are critical to determine health center
capacity to implement the vaccination program as well as comply with
program requirements. These data are used to assess program readiness
including:
Ability to safely store the vaccine
Availability of trained and credentialed staff and other staff
capacity
Reporting capacity
Sufficient PPE
Plan for vaccine transport
The health center weekly survey and addendum support HRSA's ability
to monitor progress towards the development and delivery of COVID-19
prevention, preparedness, and/or response activities; and ensure
appropriate vaccine administration as well as better understand
training and technical assistance, funding, and other health center
resource needs.
The Conditions of Participation Agreement governs all COVID-19
vaccination activities at all health center sites that receive COVID-19
vaccine through the HRSA Health Center COVID-19 Vaccine Program. Health
Centers that sign the agreement agree to adhere to each of the stated
requirements.
The PCA weekly survey increases information sharing between health
centers, PCAs, and HRSA in order to better support COVID-19 emergency
response efforts inclusive of testing and vaccination activities. Data
collected from the survey tool is used to track and monitor issues/
challenges to program implementation and assess the need for the
delivery/dissemination of targeted training and technical assistance.
Likely Respondents: HRSA-supported health centers, look-alikes, and
PCAs.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install, and utilize technology and
systems for the purpose of collecting, validating, and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
Total Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
responses to Total Average burden Total burden
Form name Number of respondents form per responses per response hours
respondent (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Condition of Participation Agreement (one-time 1,467 (Total health centers, including 1 1,467 .25 366.75
completion for vaccine program participants look-alikes, in 2019).
only).
Readiness Assessment Tool (one-time completion 1,467 (Total health centers, including 1 1,467 .50 733.50
for vaccine program participants only). look-alikes, in 2019).
Health Center COVID-19 Data Collection Survey 1,389 (Total health centers in 2019)... 48 66,672 1.00 66,672.00
Tool (weekly completion of existing 20
questions).
Addendum to COVID-19 Data Collection Survey 1,389 (Total health centers in 2019)... 48 66,672 .50 33,336.00
Tool (weekly completion for vaccine program
participants only).
PCA COVID-19 Data Collection Survey Tool (bi- 52..................................... 6 312 .75 234.00
weekly completion of existing six questions).
--------------------------------------------------------------------------------------------------------
Total...................................... 5,764.................................. .............. 136,590 .............. 101,342.25
--------------------------------------------------------------------------------------------------------------------------------------------------------
HRSA specifically requests comments on (1) the necessity and
utility of the proposed information collection for the proper
performance of the agency's functions, (2) the accuracy of the
estimated burden, (3) ways to enhance the quality, utility, and clarity
of the information to be collected, and (4) the use of automated
collection techniques or other forms of information
[[Page 41976]]
technology to minimize the information collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021-16591 Filed 8-3-21; 8:45 am]
BILLING CODE 4165-15-P
